Literature DB >> 18512901

Conformationally constrained analogues of N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4- dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716): design, synthesis, computational analysis, and biological evaluations.

Yanan Zhang1, Jason P Burgess, Marcus Brackeen, Anne Gilliam, S Wayne Mascarella, Kevin Page, Herbert H Seltzman, Brian F Thomas.   

Abstract

Structure-activity relationships (SARs) of 1 (SR141716) have been extensively documented, however, the conformational properties of this class have received less attention. In an attempt to better understand ligand conformations optimal for receptor recognition, we have designed and synthesized a number of derivatives of 1, including a four-carbon-bridged molecule (11), to constrain rotation of the diaryl rings. Computational analysis of 11 indicates approximately 20 kcal/mol energy barrier for rotation of the two aryl rings. NMR studies have determined the energy barrier to be approximately 18 kcal/mol and suggested atropisomers could exist. Receptor binding and functional studies with these compounds displayed reduced affinity and potency when compared to 1. This indicates that our structural modifications either constrain the ring systems in a suboptimal orientation for receptor interaction or the introduction of steric bulk leads to disfavored steric interactions with the receptor, and/or the relatively modest alterations in the molecular electrostatic potentials results in disfavored Coulombic interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18512901     DOI: 10.1021/jm8000778

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.

Authors:  Guanglin Kuang; Guoping Hu; Xianqiang Sun; Weihua Li; Guixia Liu; Yun Tang
Journal:  J Mol Model       Date:  2012-03-09       Impact factor: 1.810

2.  Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity.

Authors:  Alan Fulp; Katherine Bortoff; Yanan Zhang; Herbert Seltzman; Rodney Snyder; Rangan Maitra
Journal:  Bioorg Med Chem Lett       Date:  2011-08-11       Impact factor: 2.823

3.  Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor.

Authors:  Yanan Zhang; Anne Gilliam; Rangan Maitra; M Imad Damaj; Julianne M Tajuba; Herbert H Seltzman; Brian F Thomas
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

Review 4.  Endocannabinoid tone versus constitutive activity of cannabinoid receptors.

Authors:  Allyn C Howlett; Patricia H Reggio; Steven R Childers; Robert E Hampson; Nadine M Ulloa; Dale G Deutsch
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 5.  Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB1/CB2 Receptor Interaction.

Authors:  Battistina Asproni; Gabriele Murineddu; Paola Corona; Gérard A Pinna
Journal:  Molecules       Date:  2021-04-07       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.